Supplier
Mcdonough County Hospital District
Mcdonough County Hospital District was paid $553K by Medicaid between Jan 2018 and Jun 2020, across 56 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 68% of everything it billed.
33Billing provider infoMCDONOUGH COUNTY HOSPITAL DISTRICT
MACOMB, IL 61455
MACOMB, IL 61455
33aNPI1669420766assigned 05/04/2006
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$553K
24GClaims25,571
24DCodes billed56
24AFirst – last monthJan 2018 – Jun 2020
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Illinois
Rank by total paid#119 of 323
Median peer was paid$217K
This provider vs. median2.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,637 | $138K | |
| 2019 | 13,919 | $283K | |
| 2020 | 5,015 | $131K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 68% | 4,923 | 1,132 | $374K |
| 97161 | 4.6% | 295 | 228 | $25K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.5% | 915 | 869 | $25K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.9% | 801 | 764 | $21K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.7% | 802 | 765 | $21K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.0% | 532 | 464 | $11K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.6% | 396 | 304 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.4% | 1,270 | 1,225 | $8K |
| 80053 | Comprehensive metabolic panel | 1.2% | 2,107 | 1,871 | $6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 64 | 63 | $6K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.1% | 448 | 150 | $6K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 103 | 27 | $5K |
44 more codes
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 94 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,539 | $4K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 354 | $4K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 370 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 321 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 933 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 255 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 828 | $1K |
| 80061 | Lipid panel | <1% | 979 | $1K |
| 84439 | <1% | 586 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 18 | $809.84 |
| 85610 | <1% | 697 | $796.78 | |
| 85027 | <1% | 532 | $752.35 | |
| 83655 | <1% | 56 | $507.76 | |
| 87186 | <1% | 130 | $489.60 | |
| 87510 | <1% | 116 | $460.99 | |
| 86780 | <1% | 149 | $445.96 | |
| 87480 | <1% | 116 | $421.10 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 18 | $390.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 128 | $358.78 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 39 | $354.78 |
| 84702 | <1% | 98 | $323.64 | |
| 87276 | <1% | 53 | $321.09 | |
| 83550 | <1% | 113 | $233.07 | |
| 80164 | <1% | 121 | $219.85 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 16 | $195.17 |
| 81001 | <1% | 187 | $187.21 | |
| 87275 | <1% | 53 | $176.60 | |
| 86901 | <1% | 134 | $160.30 | |
| 86900 | <1% | 157 | $158.53 | |
| 86850 | <1% | 151 | $148.23 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 72 | $133.62 |
| 82950 | <1% | 153 | $124.97 | |
| 87660 | <1% | 116 | $114.66 | |
| 86765 | <1% | 37 | $111.72 | |
| 83540 | <1% | 117 | $108.72 | |
| 87340 | <1% | 42 | $85.41 | |
| 82570 | <1% | 74 | $81.71 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,866 | $79.91 |
| 81002 | <1% | 30 | $25.58 | |
| 82728 | <1% | 24 | $24.36 | |
| 82947 | <1% | 17 | $18.60 | |
| 85651 | <1% | 12 | $13.44 | |
| 86592 | <1% | 14 | $3.90 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDIETZ, BRIAN (PRESIDENT, CEO)
| Provider | Location | Paid |
|---|---|---|
| Mcdonough County Hospital District | Macomb, IL | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.